AzTrials
AzTrials

StrokePhase 1NCT02667392

Biofeedback to Increase Propulsion During Walking After Stroke

A Phase 1 study testing Gait Training with Biofeedback and Gait Training with Verbal Feedback in people with Stroke, run by VA Office of Research and Development at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Approximately 15,000 Veterans are hospitalized for stroke each year with new cases costing an estimated $111 million for acute inpatient, $75 million for post-acute inpatient, and $88 million for follow-up care over 6 months post-stroke. Rehabilitation of walking ability contributes to these costs. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke
What is being tested?
Gait Training with Biofeedback and Gait Training with Verbal Feedback
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
11 participants
Where
1 siteUnited States
Study dates
2 Oct 2017to 30 Sep 2019
Phase
Phase 1
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of stroke
  • > 6 months < 5 years post-stroke onset
  • Medically stable
  • 18-80 years of age
  • Impaired lower extremity sensation confirmed by a score of < 12 on the Fugl-Meyer Sensory Assessment,20
  • Community-dwelling
Show all 12Show fewer
  • Step length asymmetry (paretic step length > non-paretic step length)
  • this asymmetry has been determined to be correlated with minimal propulsive force of the paretic leg4
  • Unilateral lower extremity paresis confirmed by a score of < 32 on the Fugl-Meyer Motor Assessment,20
  • Able to ambulate without an orthotic device
  • Able to ambulate without an assistive device
  • Ambulation of household distances without physical assistance to advance or support paretic lower extremity

Who cannot join

  • Presence of a neurological condition other than stroke
  • Pain upon ambulation
  • Receiving physical therapy services for mobility and/or gait
  • Severe arthritis or orthopedic problems that limit passive ranges of motion
  • knee flexion contracture of -10 , knee flexion range of motion (ROM) < 90
  • hip flexion contracture > 25
  • ankle plantar flexion contracture > 15

Trial locations and contacts

1 site in 1 country.

United States1 site
  • North Florida/South Georgia Veterans Health System, Gainesville, FL

    Gainesville, Florida, 32608

Other trials in United States

About this study

Approximately 15,000 Veterans are hospitalized for stroke each year with new cases costing an estimated $111 million for acute inpatient, $75 million for post-acute inpatient, and $88 million for follow-up care over 6 months post-stroke. Rehabilitation of walking ability contributes to these costs. To "walk again" is the number one stated goal for Veterans who have had a stroke. Teaching patients post-stroke to use their weak leg while they are regaining walking function and to not compensate by over-using their strong leg is necessary to restore safe, efficient walking ability. This project will determine if providing biofeedback (an audible tone) from pressure-sensitive shoe insole sensors, that encourage use of the weaker leg during walking training, in addition to therapists' feedback, will help Veterans regain use of their weak leg, improve their endurance and improve their balance when walking in challenging environments.

Read the detailed description

Background/Purpose: Approximately 15,000 Veterans are hospitalized for stroke each year. Impairments of motor control and the subsequent functional limitations in ambulation are the most common manifestations and regaining the ability to walk is the number one stated goal of Veteran stroke survivors. Forward propulsion of the body's center of mass is a cardinal feature of gait that depends on the generation of appropriate anterior-posterior ground reaction forces. Decreased propulsive force generation by the paretic limb of stroke survivors has been identified through both simulation and cross-sectional studies as a major contributor to walking dysfunction. Extrinsic verbal feedback from a therapist is the standard approach used during gait retraining to improve propulsion generation. However, this key component of gait is not directly observable by therapists and patients are often unable to sense propulsion generation due to impaired intrinsic feedback, specifically deficits in somatosensation and proprioception, hindering recovery of paretic propulsion and compromising walking function. The objective of this study is to provide preliminary evidence that biofeedback as an adjuvant to therapists' verbal feedback will improve propulsion and enhance walking function for Veterans post-stroke.

Subjects: Thirty individuals > 6-months post-stroke will participate. Additional study criteria include: 1) Ambulation of household distances without physical assistance to advance or support the paretic leg; 2) Unilateral leg paresis confirmed by a score of < 32 on the Fugl-Meyer Motor Assessment; 3) Step length asymmetry (paretic > non-paretic step length); 4) Ambulation without an assistive or orthotic device.

Methods: Participants will be randomized to either an experimental group that will train with propulsion biofeedback from commercially available pressure-sensitive insole sensors (Biofeedback group; n=15) or a control group that will train with standard therapist-provided verbal feedback alone (Standard group; n=15). The 12 session (3X/week for 4 weeks) gait training intervention will be delivered by a physical therapist-led team. For participants in the Biofeedback group, prior to the first intervention session, the baseline amount of pressure exerted by the paretic forefoot during late stance will be determined. The insole area underlying the forefoot will then be calibrated to produce a tone when pressure exceeds 5% of this baseline pressure. This threshold will be progressively increased at regular intervals throughout the intervention period to ensure participants are training at their challenge-point to improve propulsion of the paretic limb. An insole of similar thickness will be worn in the shoe of the non-paretic leg for symmetry and comfort but will not produce a tone during the intervention. Those in the Standard group will not wear insoles during intervention but will receive verbal feedback alone regarding propulsion of the paretic limb during gait training. Therapist-provided verbal feedback will be used to instruct participants on achieving and/or maintaining appropriate movement patterns that contribute to propulsion generation. For both groups, the therapist will choose from a standardized bank of gait activities, suitable to each participant's ability level. The goal for total walking time for each session will be 50 minutes: 5, 10-minute bouts with a 2-minute rest between each bout.

Outcome Measures: Paretic limb propulsion is the primary outcome measure. Secondary measures include the Six Minute Walk Test, Functional Gait Assessment, Fall Self-Efficacy, temporal-distance gait measures and gait kinematics, all of which will be measured pre- and post-intervention.

Data Analysis Plan: Descriptive statistics will be provided for all outcome measures. To identify the effect of the intervention, differences between the pre- and post-training assessment within each group (i.e. change scores) will be calculated. To test the hypotheses, the investigators will apply independent sample t-tests to the change scores of the Biofeedback and Standard group. Hypothesis testing will be conducted at a two-sided p < 0.05 level.

Conditions
Stroke
Being tested
Gait Training with Biofeedback, Gait Training with Verbal Feedback
Keywords
Stroke, Gait, Walking, Rehabilitation, Exercise, Exercise Therapy, Physical Therapy Modalities, Exercise Movement Techniques
Medical subject headings
Stroke, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gait Training with BiofeedbackProcedure or surgery

    Intervention (12, 60-minute sessions, 3X/week for four weeks) will occur in an outpatient research setting. Participants will be supervised by a licensed physical therapist and wear a gait belt during all activities. The therapist will choose from a standardized bank of gait activities, suitable to each participant's ability level. The goal for total walking time for each session will be 50 minutes: 5, 10-minute bouts with a 2-minute rest between bouts. This is the typical length and intensity of outpatient rehabilitation sessions for ambulatory patients discharged from inpatient rehabilitation.

    Biofeedback Group: Biofeedback (external-focus feedback) will be provided as an adjuvant to therapist-provided feedback during the intervention. Participants will be instructed that a tone will sound when they "push off with their (paretic) leg to swing it forward" when the participant-specific pre-programmed threshold is exceeded.

  • Gait Training with Verbal FeedbackProcedure or surgery

    Intervention (12, 60-minute sessions, 3X/week for four weeks) will occur in an outpatient research setting. Participants will be supervised by a licensed physical therapist and wear a gait belt during all activities. The therapist will choose from a standardized bank of gait activities, suitable to each participant's ability level. The goal for total walking time for each session will be 50 minutes: 5, 10-minute bouts with a 2-minute rest between bouts. This is the typical length and intensity of outpatient rehabilitation sessions for ambulatory patients discharged from inpatient rehabilitation.

    Verbal Feedback Group: Therapist-provided internal-focus feedback ("directed towards components of body movement") will be used to instruct participants on achieving and/or maintaining appropriate movement patterns that contribute to propulsion generation.

Study groups in NCT02667392
Study groupRoleWhat they receive
Biofeedback GroupExperimentalParticipants will wear a pressure-sensitive insole inside the shoe of their paretic limb. An auditory tone will sound when participants have provided sufficient load to active the pressure-sensitive in-sole.
Receives: Procedure: Gait Training with Biofeedback
Verbal Feedback GroupActive comparatorParticipants will receive verbal feedback from a physical therapist regarding the amount of loading they are exerting on their paretic limb.
Receives: Procedure: Gait Training with Verbal Feedback

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change From Baseline in Forward Propulsion of the Paretic Limb From Pre- to Post-intervention

    The propulsive impulse will be derived from the time integral of the positive anterior-posterior ground reaction force for the paretic leg normalized to Body Weight.

    Measured: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.

Secondary outcomes (10)
  1. Change From Baseline in Peak Hip Flexion Range of Motion, in Degrees, of the Paretic Leg From Pre- to Post-intervention

    Hip motion data will be acquired using a modified Helen Hayes marker set with rigid clusters on the pelvis and each thigh and reflective markers at the greater trochanter and the lateral condyle of the femur. The angle formed between the rigid cluster on the pelvis and the lateral condyle of the femur will be recorded at 100 Hz using a 12 camera motion capture system. The peak value from 10 gait cycles was averaged to obtain an average peak value.

    Measured: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.

  2. Change From Baseline in Stride Time From Pre to Post-intervention.

    Data will be acquired while walking across a GAITRite instrumented walkway.

    Measured: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.

  3. Change From Baseline in Distance Covered During the Six Minute Walk Test From Pre- to Post-intervention

    Participants will walk for a total of six minutes at their comfortable walking speed and the total distance will be recorded.

    Measured: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.

  4. Change From Baseline in the Functional Gait Assessment Score From Pre- to Post-intervention

    Ten item gait and balance test during which participants walk forwards, backwards, ascend/descend stairs, walk with head turning and step over obstacles. Score ranges from 0-30 with a larger number indicative of a better outcome. Each item is scored on a 0-4 scale with a lower number representing greater impairment. The individual score on each of the ten items are summed for a total score with a larger number indicative of a better outcome.

    Measured: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.

  5. Change From Baseline in the Modified Falls Efficacy Scale From Pre- to Post-intervention

    Fourteen item questionnaire designed to measure self-perceived fear of falling during task performance. Score range is between 0-10 with a higher score indicative of a better outcome

    Measured: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.

  6. Change From Baseline in Paretic Limb Step Time From Pre- to Post-intervention.

    Footfall of both limbs will be acquired while participants walk across a pressure sensitive instrumented walkway (GAITRite). From these footballs paretic step time will be calculated.

    Measured: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.

  7. Change From Baseline in Paretic Limb Stride Length From Pre to Post-intervention.

    Footfalls from both limbs will be acquired as participant walks across a pressure-sensitive instrumented walkway (GAITRite). From these footfalls will be used to calculate paretic limb stride length.

    Measured: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.

  8. Change From Baseline in Paretic Limb Step Length From Pre to Post-intervention.

    Footfalls from both limbs will be acquired as participant walks across a pressure-sensitive instrumented walkway (GAITRite). From these footfalls will be used to calculate paretic limb step length.

    Measured: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.

  9. Change From Baseline in Paretic Limb Step Width From Pre to Post-intervention.

    Footfalls from both limbs will be acquired as participant walks across a pressure-sensitive instrumented walkway (GAITRite). From these footfalls will be used to calculate paretic limb step width.

    Measured: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.

  10. Change From Baseline in Gait Speed From Pre to Post-intervention.

    Data will be acquired while participants walk across a pressure-sensitive 14 meter instrumented walkway (Brand Name: GAITRite).

    Measured: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2016 (estimated)
  2. Study start2 Oct 2017
  3. Primary completion16 Sep 2019
  4. Study completion30 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel: participants are assigned to one of two or more groups in parallel for the duration of the study.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
11 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02667392
Sponsor's protocol ID
N2051-P
Status last verified
Feb 2021
First submitted
19 Jan 2016
Last updated
21 Feb 2021
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Gait Training with Biofeedback and Gait Training with Verbal Feedback in people with Stroke, run by VA Office of Research and Development at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 21 Feb 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change From Baseline in Forward Propulsion of the Paretic Limb From Pre- to Post-intervention (time frame: Pre-intervention (prior to 1st intervention session) and Post-intervention (after the final (12th intervention session), approximately 4 weeks after entering the study.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2021; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in